China is expected to soon announce a massive investment in precision medicine, with plans to spend $9 billion over the next fifteen years. The effort will combine genomic sequencing and clinical patient data to tailor medical treatments to individuals, with the goal of improving care and curtailing waste. China’s investment dwarfs a similar US initiative. One year ago, the US announced a $215 million plan, run by the National Institutes of Health, though that effort was spread over just four years. Some of China’s money will be allocated to develop new drugs, based on research discoveries. More
